Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C, Genotype 1”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01459913
What this trial is testing

Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 239
Testing effectiveness (Phase 2)Study completedNCT01025596
What this trial is testing

Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)

Who this might be right for
Hepatitis C
Cytheris SA 10
Post-approval studies (Phase 4)WithdrawnNCT02485080
What this trial is testing

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1

Who this might be right for
PT-NANBH
Stanford University
Post-approval studies (Phase 4)WithdrawnNCT02292966
What this trial is testing

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism

Who this might be right for
Hepatitis C, Chronic
Kirby Institute
Testing effectiveness (Phase 2)Study completedNCT00535847
What this trial is testing

A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 117
Testing effectiveness (Phase 2)UnknownNCT01872936
What this trial is testing

Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Santaris Pharma A/S 20
Post-approval studies (Phase 4)Study completedNCT01405027
What this trial is testing

Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy

Who this might be right for
Chronic Hepatitis CGenotype 1
Chronic Liver Disease Foundation 197
Large-scale testing (Phase 3)Study completedNCT01544920
What this trial is testing

Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 737
Testing effectiveness (Phase 2)Study completedNCT01010646
What this trial is testing

Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 84
Not applicableStudy completedNCT00703560
What this trial is testing

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients

Who this might be right for
Hepatitis C
University of Texas Southwestern Medical Center 72
Testing effectiveness (Phase 2)Study completedNCT02716779
What this trial is testing

Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 68
Large-scale testing (Phase 3)Study completedNCT01289782
What this trial is testing

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 395
Testing effectiveness (Phase 2)Study completedNCT01909804
What this trial is testing

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 323
Early research (Phase 1)Study completedNCT02116543
What this trial is testing

TD-6450 MAD Study in HCV Infected Subjects

Who this might be right for
Hepatitis CHCV
Theravance Biopharma 47
Large-scale testing (Phase 3)WithdrawnNCT01797848
What this trial is testing

Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT01928147
What this trial is testing

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Presidio Pharmaceuticals, Inc. 114
Large-scale testing (Phase 3)UnknownNCT04001608
What this trial is testing

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients

Who this might be right for
Hepatitis C Virus Infection
Ginkgopharma CO., LTD 206
Testing effectiveness (Phase 2)Study completedNCT02243280
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 174
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Testing effectiveness (Phase 2)Study completedNCT01125189
What this trial is testing

Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 558
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation